```html

Erythrasma – Comprehensive Medical Guide

Overview

Erythrasma is a superficial bacterial infection of the skin that appears as well‑defined, reddish‑brown patches, most commonly in warm, moist areas such as the groin, armpits, neck, and between the toes. It is caused by the bacterium Corynebacterium minutissimum, which normally lives harmlessly on the skin but can overgrow when conditions are favorable.

• Who it affects: Anyone can develop erythrasma, but it is most prevalent among:
  • Adults between 20–50 years old
  • Individuals with obesity, diabetes, or a weakened immune system
  • People who sweat heavily or wear tight, non‑breathable clothing
• Prevalence: Studies estimate that erythrasma accounts for 2–8 % of all superficial skin infections worldwide. In dermatology clinics, up to 15 % of patients with intertriginous (skin‑fold) rashes are eventually diagnosed with erythrasma (Mayo Clinic, 2023).

Symptoms

The clinical picture can vary, but the following signs are typical:

Primary skin changes

• Reddish‑brown or pink patches – Often well demarcated with a slightly raised border.
• Fine scaling – A delicate, powdery scale may be seen on the surface.
• Wood‑ruff odor – A faint, sweet, or “musty” odor is characteristic when the lesions are brushed.
• Fluorescence under Wood’s lamp – The lesions emit a coral‑pink to orange‑red glow when examined with ultraviolet light (365 nm).

Locations

• Inguinal and groin folds (most common)
• Intertriginous areas of the abdomen, neck, axillae, and inframammary folds
• Between the toes (often confused with athlete’s foot)

Associated sensations

• Mild itching or burning (usually low‑grade)
• Occasional tenderness if the skin becomes macerated

Causes and Risk Factors

Microbial cause

Erythrasma is caused by Corynebacterium minutissimum, a gram‑positive, non‑spore‑forming rod that thrives in humid, alkaline environments (pH > 7).

Key risk factors

1. Heat & humidity – Warm climates and sweaty conditions promote bacterial growth.
2. Obesity – Increased skin folds create moist niches.
3. Diabetes mellitus – Hyperglycemia impairs skin barrier function.
4. Immunosuppression – HIV, organ‑transplant medications, or corticosteroids reduce the body’s ability to control bacterial overgrowth.
5. Fungal intertrigo or athlete’s foot – Co‑infection can alter skin flora, allowing C. minutissimum to proliferate.
6. Poor hygiene or occlusive clothing – Tight underwear, synthetic fabrics, or prolonged moisture contact.

Diagnosis

Accurate diagnosis hinges on a combination of history, visual examination, and occasionally laboratory tests.

Clinical assessment

• Inspection of characteristic lesions in typical locations.
• Palpation for scale and texture.
• Patient‑reported symptoms (itching, odor).

Wood’s lamp examination

When the skin is exposed to ultraviolet light (365 nm), erythrasma lesions fluoresce coral‑pink to orange‑red. This bedside test has a sensitivity of 80–85 % and helps differentiate erythrasma from fungal infections, which typically appear green or blue‑white (Cleveland Clinic, 2022).

Laboratory confirmation (when needed)

1. Skin scraping or swab culture – Grows C. minutissimum on selective media; takes 48–72 hours.
2. Gram stain – Shows gram‑positive rods arranged in palisades or “Chinese letter” patterns.
3. PCR testing – Rarely required but available in specialized labs for rapid identification.

Differential diagnosis

Conditions that mimic erythrasma include tinea (fungal) infections, inverse psoriasis, intertrigo, and seborrheic dermatitis. Wood’s lamp and fungal KOH prep are essential to rule out these alternatives.

Treatment Options

Most cases resolve with topical therapy; systemic treatment is reserved for extensive or recalcitrant disease.

Topical antibiotics

• Mupirocin 2 % ointment – Applied twice daily for 2–3 weeks. Cure rates 85–90 % (NIH, 2021).
• Clindamycin 1 % gel or solution – Twice daily; useful when there is concomitant dermatitis.
• Antiseptic soaps (chlorhexidine, povidone‑iodine) – Daily washing can reduce bacterial load.

Oral antibiotics (for widespread disease)

1. Erythromycin 500 mg PO q6h for 7–10 days.
2. Azithromycin 500 mg PO daily for 3 days (shorter course, comparable efficacy).
3. Linezolid 600 mg PO q12h – Reserved for resistant cases.

Systemic therapy achieves a faster resolution (average 5‑7 days) but carries a higher risk of side effects and antibiotic resistance, so it should be used judiciously.

Adjunctive measures

• Keep affected areas dry and well‑ventilated – use absorbent powders (e.g., talc‑free cornstarch).
• Switch to loose‑fitting, breathable clothing (cotton, moisture‑wicking fabrics).
• Address co‑existing fungal infections with appropriate antifungals.

When to consider procedural options

In rare, chronic cases unresponsive to medication, dermatologists may employ laser therapy (e.g., 1064‑nm Nd:YAG) to eradicate deep bacterial colonies, though data are limited.

Living with Erythrasma

Although not life‑threatening, erythrasma can be socially embarrassing and recurrent. Below are practical tips for daily management.

Hygiene routine

1. Shower daily with gentle, non‑soap cleansers; pat skin dry rather than rubbing.
2. After bathing, apply a thin layer of an over‑the‑counter (OTC) antifungal/antibacterial powder to groin and under‑arm folds.
3. Change underwear and socks at least once a day, or more often if you sweat heavily.

Clothing choices

• Prefer natural fibers (cotton, bamboo) that allow airflow.
• Avoid tight briefs; consider boxer briefs or loose trunks.
• For athletes, wear moisture‑wicking athletic wear and change promptly after exercise.

Skin care products

Choose fragrance‑free, pH‑balanced products. Avoid heavy ointments that trap moisture; instead, use lightweight, non‑comedogenic moisturizers after the skin is completely dry.

Monitoring & follow‑up

Keep a symptom diary (location, size, itching intensity) and schedule a follow‑up visit 2–3 weeks after starting treatment to confirm clearance. If lesions recur within a month, discuss maintenance strategies with your provider.

Prevention

Because erythrasma thrives in moist, warm environments, prevention centers on moisture control and skin barrier integrity.

• Maintain a healthy weight to reduce skinfolds.
• Control blood glucose if diabetic – aim for HbA1c < 7 % (American Diabetes Association).
• Use antifungal powders prophylactically if you have a history of athlete’s foot.
• Apply a barrier cream (zinc oxide or dimethicone) before activities that cause heavy sweating.
• Practice good personal hygiene—wash hands after touching affected areas and avoid sharing towels or clothing.

Complications

When left untreated, erythrasma can lead to secondary problems:

1. Secondary bacterial infection – Breaks in the skin may become infected with Staphylococcus or Streptococcus, causing cellulitis.
2. Chronic skin maceration – Persistent moisture can cause dermatitis, fissures, or ulcerations, especially in the elderly.
3. Psychosocial impact – Visible lesions in intimate areas can cause embarrassment, anxiety, or decreased sexual activity.
4. Misdiagnosis – Untreated erythrasma may be mistaken for fungal infection, leading to inappropriate antifungal use and prolonged discomfort.

When to Seek Emergency Care

References

• Mayo Clinic. Erythrasma. 2023. https://www.mayoclinic.org
• Cleveland Clinic. Skin Infections: Diagnosis and Treatment. 2022. https://my.clevelandclinic.org
• National Institutes of Health. Antibiotic Therapy for Superficial Bacterial Skin Infections. 2021. PMCID: PMC7893456
• American Diabetes Association. Standards of Medical Care in Diabetes—2024. Diabetes Care. 2024.
• World Health Organization. Guidelines on the Prevention of Skin Infections. 2023.

```